您的购物车当前为空
(S)-α-Methylbenzyl ricinoleamide is a fatty acid amide derived from ricinoleic acid and methyl benzylamine. It demonstrates potent growth inhibition of glioma (U251), breast (MCF-7), ovarian (NCI-ADR/RES and OVCAR-3), kidney (786-0), non-small cell lung (NCI-H460), and prostate (PC-3) cancer cells with a mean GI50 value of 6.9 μM.

(S)-α-Methylbenzyl ricinoleamide is a fatty acid amide derived from ricinoleic acid and methyl benzylamine. It demonstrates potent growth inhibition of glioma (U251), breast (MCF-7), ovarian (NCI-ADR/RES and OVCAR-3), kidney (786-0), non-small cell lung (NCI-H460), and prostate (PC-3) cancer cells with a mean GI50 value of 6.9 μM.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 812 | 35日内发货 | |
| 5 mg | ¥ 3,520 | 35日内发货 | |
| 10 mg | ¥ 6,160 | 35日内发货 | |
| 25 mg | ¥ 13,500 | 35日内发货 |
| 产品描述 | (S)-α-Methylbenzyl ricinoleamide is a fatty acid amide derived from ricinoleic acid and methyl benzylamine. It demonstrates potent growth inhibition of glioma (U251), breast (MCF-7), ovarian (NCI-ADR/RES and OVCAR-3), kidney (786-0), non-small cell lung (NCI-H460), and prostate (PC-3) cancer cells with a mean GI50 value of 6.9 μM. |
| 分子量 | 401.63 |
| 分子式 | C26H43NO2 |
| CAS No. | 1246776-22-6 |
| 密度 | no data available |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| 溶解度信息 | DMF: 30 mg/mL (74.7 mM), Sonication is recommended. Ethanol:PBS (pH 7.2) (1:3): 0.25 mg/mL (0.62 mM), Sonication is recommended. DMSO: 25 mg/mL (62.25 mM), Sonication is recommended. Ethanol: 30 mg/mL (74.7 mM), Sonication is recommended. |
评论内容